A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trials
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Atopic Dermatitis
Related studies linked through entity extraction aliases.
Effects of Fucoidan on the Gut Microbiota in the Patients of Atopic Dermatitis
- Status
- UNKNOWN
- Phase
- NA
Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis
- Status
- COMPLETED
- Phase
- PHASE4
Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
A Study of TQH2722 Injection to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Immunogenicity in Healthy Adult Subjects
- Status
- UNKNOWN
- Phase
- PHASE1
An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis
- Status
- TERMINATED
- Phase
- PHASE2
A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)
- Status
- COMPLETED
- Phase
- PHASE3
An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing Dupilumab
- Status
- COMPLETED
- Phase
- N/A
Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis
- Status
- TERMINATED
- Phase
- PHASE3
A First-In-Human Study to Evaluate the Safety, Tolerability, and Efficacy of Si-544 in Adults With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE1
Effects of Tralokinumab in the Skin: an Immunologic and Molecular Investigation
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India
- Status
- COMPLETED
- Phase
- PHASE3
A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color
- Status
- COMPLETED
- Phase
- PHASE3
IL-4 and Insulin Resistance for Treatment of Patients With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab
- Status
- COMPLETED
- Phase
- PHASE3
Atopic Dermatitis: Sub-Saharan Africa vs. Central Europe
- Status
- COMPLETED
- Phase
- N/A
Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.
- Status
- UNKNOWN
- Phase
- N/A